TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 1.3B
Gross Profit 753.0M 58.92%
Operating Income 11.0M 0.86%
Net Income -58.0M -4.54%
EPS (Diluted) $-0.18

Balance Sheet Metrics

Total Assets 13.4B
Total Liabilities 7.0B
Shareholders Equity 6.4B
Debt to Equity 1.09

Cash Flow Metrics

Operating Cash Flow -32.0M
Free Cash Flow -135.0M

Revenue & Profitability Trend

Bausch + Lomb Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.8B4.1B3.8B3.8B3.4B
Cost of Goods Sold i1.9B1.6B1.5B1.5B1.3B
Gross Profit i2.9B2.5B2.2B2.3B2.1B
Gross Margin % i60.9%60.4%59.7%61.0%62.3%
Operating Expenses
Research & Development i343.0M324.0M308.0M276.0M281.0M
Selling, General & Administrative i2.1B1.7B1.5B1.4B1.3B
Other Operating Expenses i-----
Total Operating Expenses i2.4B2.1B1.8B1.7B1.5B
Operating Income i206.0M204.0M219.0M341.0M270.0M
Operating Margin % i4.3%4.9%5.8%9.1%7.9%
Non-Operating Items
Interest Income i15.0M15.0M6.0M03.0M
Interest Expense i399.0M283.0M146.0M00
Other Non-Operating Income-56.0M-102.0M-6.0M-23.0M17.0M
Pre-tax Income i-234.0M-166.0M73.0M318.0M290.0M
Income Tax i71.0M82.0M58.0M125.0M307.0M
Effective Tax Rate % i0.0%0.0%79.5%39.3%105.9%
Net Income i-305.0M-248.0M15.0M193.0M-17.0M
Net Margin % i-6.4%-6.0%0.4%5.1%-0.5%
Key Metrics
EBITDA i657.0M601.0M604.0M757.0M714.0M
EPS (Basic) i$-0.90$-0.74$0.02$0.52$-0.05
EPS (Diluted) i$-0.90$-0.74$0.02$0.52$-0.05
Basic Shares Outstanding i351800000350500000350000000350000000350000000
Diluted Shares Outstanding i351800000350500000350000000350000000350000000

Income Statement Trend

Bausch + Lomb Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i305.0M331.0M354.0M174.0M238.0M
Short-term Investments i-----
Accounts Receivable i1.0B839.0M724.0M721.0M645.0M
Inventory i1.0B1.0B628.0M572.0M616.0M
Other Current Assets410.0M541.0M405.0M165.0M155.0M
Total Current Assets i2.8B2.7B2.1B1.6B1.7B
Non-Current Assets
Property, Plant & Equipment i00335.0M232.0M204.0M
Goodwill i12.5B12.7B11.1B11.4B11.9B
Intangible Assets i3.5B3.6B2.1B2.3B2.6B
Long-term Investments-----
Other Non-Current Assets1.2B1.1B1.1B1.1B1.2B
Total Non-Current Assets i10.7B10.7B9.0B9.2B9.6B
Total Assets i13.5B13.4B11.1B10.8B11.3B
Liabilities
Current Liabilities
Accounts Payable i389.0M522.0M370.0M239.0M178.0M
Short-term Debt i40.0M30.0M25.0M28.0M-
Current Portion of Long-term Debt-----
Other Current Liabilities403.0M400.0M342.0M316.0M278.0M
Total Current Liabilities i1.7B1.6B1.3B1.1B909.0M
Non-Current Liabilities
Long-term Debt i4.7B4.5B2.4B--
Deferred Tax Liabilities i13.0M14.0M7.0M24.0M27.0M
Other Non-Current Liabilities430.0M397.0M329.0M298.0M342.0M
Total Non-Current Liabilities i5.2B4.9B2.7B322.0M369.0M
Total Liabilities i6.9B6.5B4.0B1.4B1.3B
Equity
Common Stock i000010.8B
Retained Earnings i-571.0M-254.0M6.0M0-
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i6.5B6.9B7.1B9.4B10.0B
Key Metrics
Total Debt i4.8B4.6B2.4B28.0M0
Working Capital i1.0B1.2B841.0M536.0M745.0M

Balance Sheet Composition

Bausch + Lomb Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-305.0M-248.0M15.0M193.0M-17.0M
Depreciation & Amortization i436.0M382.0M379.0M415.0M442.0M
Stock-Based Compensation i92.0M74.0M62.0M62.0M50.0M
Working Capital Changes i-248.0M-140.0M-12.0M41.0M-99.0M
Operating Cash Flow i48.0M110.0M339.0M825.0M470.0M
Investing Activities
Capital Expenditures i-291.0M-181.0M-175.0M-193.0M-253.0M
Acquisitions i-138.0M-1.9B-45.0M-16.0M0
Investment Purchases i-12.0M-17.0M-17.0M-19.0M-6.0M
Investment Sales i14.0M16.0M22.0M14.0M9.0M
Investing Cash Flow i-425.0M-2.1B-215.0M-214.0M-250.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i631.0M2.3B2.5B28.0M0
Debt Repayment i-430.0M-161.0M-13.0M00
Financing Cash Flow i178.0M2.1B81.0M-712.0M-232.0M
Free Cash Flow i-59.0M-198.0M170.0M680.0M263.0M
Net Change in Cash i-199.0M66.0M205.0M-101.0M-12.0M

Cash Flow Trend

Bausch + Lomb Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -16.89
Forward P/E 12.77
Price to Book 0.84
Price to Sales 1.10
PEG Ratio 0.29

Profitability Ratios

Profit Margin -5.58%
Operating Margin 0.86%
Return on Equity -4.02%
Return on Assets 0.47%

Financial Health

Current Ratio 1.55
Debt to Equity 76.20
Beta 0.63

Per Share Data

EPS (TTM) $-0.78
Book Value per Share $18.20
Revenue per Share $13.87

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
blco5.4B-16.890.84-4.02%-5.58%76.20
Intuitive Surgical 163.3B63.009.0816.04%28.51%0.00
Becton, Dickinson 55.7B35.462.186.18%7.41%75.93
Avantor 9.7B14.151.5511.73%10.31%67.49
Align Technology 9.7B22.332.4511.41%11.04%3.14
AptarGroup 8.8B23.013.2515.26%10.84%43.12

Financial data is updated regularly. All figures are in the company's reporting currency.